Thalidomide, 98%, initially promoted as a sedative, inhibits cereblon (CRBN), with a Kd of ~250 nM, and has immunomodulatory, anti-inflammatory and anti-angiogenic cancer propertiesLY-JK-374892
產品編號:
LY-JK-374892純度:98%CAS:50-35-1
英文名稱:Thalidomide, 98%, initially promoted as a sedative, inhibits cereblon (CRBN), with a Kd of ~250 nM, and has immunomodulatory, anti-inflammatory and anti-angiogenic cancer properties
Thalidomide, 98%, initially promoted as a sedative, inhibits cereblon (CRBN), with a Kd of ~250 nM, and has immunomodulatory, anti-inflammatory and anti-angiogenic cancer properties